None — 12-year-old Remi Savioz was diagnosed with a rare neuro-metabolic brain disease called Glucose Transporter 1, which affects the amount of glucose that reaches the brain. She is one of only 200 ...

The investigatory studies on blood were exempted from full review and approved by the Columbia University Institutional Review Board. Informed consent was obtained from the parents and patients who ...

A deficiency in the protein responsible for moving glucose across the brain's protective blood-brain barrier appears to intensify the neurodegenerative effects of Alzheimer's disease, according to a ...

Novato, CA, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, ...

University of Texas at Arlington. "Challenging the current approach to Glut1 deficiency." ScienceDaily. ScienceDaily, 24 April 2017. <www.sciencedaily.com / releases / 2017 / 04 / 170424141230.htm>.

METAglut1TM obtains universal national coverage by French National Health Insurance as of February 22, 2024 Nationwide, patients with suspected Glut1 deficiency syndrome will benefit from ...

TWIST1 is a major regulator of epithelial mesenchymal transition process, essential in cancer metastasis. Cancer cells increase glucose uptake capabilities to meet their high energy requirements. In ...